Incorporating New Therapies to Hone the Treatment of Resistant or Refractory CMV in the Post-SOT Setting: Proceedings from a Clinical Olympics

Program Overview

Join Drs. Kotton, Pereira, and Razonable as they discuss the management of cytomegalovirus (CMV) infection in solid organ transplant (SOT) patients. Topics covered include treatment challenges, laboratory testing, and new therapy for refractory or resistant CMV.

1.0 CE Credit(s)
Expires: July 11, 2024

Target Audience

Infectious disease, transplantation, internal medicine, and pharmacy clinicians managing patients with CMV

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Apply treatment strategies with established antiviral therapies to solid organ transplant (SOT) recipients who develop cytomegalovirus (CMV) in the post-transplant setting
  • Identify SOT recipients who develop treatment-resistant or refractory CMV in the post-transplant setting
  • Integrate new antiviral therapies into management regimens for resistant or refractory CMV in the post-SOT setting

Activity Faculty

Camille Kotton portrait 2021

Camille Nelson Kotton, MD, FIDSA, FAST

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Associate Professor, Medicine
Harvard Medical School
Boston, MA

62-23-1044-SM-002 ATC 2023-Faculty Photo Marcus_Pereira 1200X1500

Marcus R. Pereira, MD, MPH, FAST

Associate Professor, Medicine
Medical Director, Transplant Infectious Diseases Program
Columbia University Irving Medical Center
NewYork Presbyterian Hospital
New York, NY


Raymund R. Razonable, MD, FIDSA, FAST 

Professor, Medicine
Program Director, Infectious Diseases Fellowship Program
Vice Chair, Division of Infectious Diseases
Mayo Clinic
Rochester, MN


Supporter Statement

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Provider Statement

Provided by RMEI Medical Education, LLC

Disclosure of Financial Relationships


Planners and Managers

Disclosure of Financial Relationships 

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. 


Camille Nelson Kotton, MD, FIDSA, FAST, has relevant financial relationships with Abbott Laboratories, Biotest, Evrys, Exevir, Hookipa, Merck, Oxford Immunotec, QIAGEN, Roche Diagnostics, Takeda (Consultant).

Marcus R. Pereira, MD, MPH, FAST, has relevant financial relationships with Takeda (Consultant).

Raymund R. Razonable, MD, FIDSA, FAST, has relevant financial relationships with Gilead, Regeneron, Roche (Grant/Research Support); Merck (Other: Data Adjudication Committee).

All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies. 

Planners and Managers

RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.

Joint Accreditation Statement 

In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

Physician Continuing Medical Education 
RMEI Medical Education, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education 
RMEI Medical Education, LLC designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008290-0000-23-007-H01-P)
Type of Activity: Knowledge

American Board of Internal Medicine Maintenance of Certification 

ABIM MOC AccreditedSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Instructions for Receiving Credit 

In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. You must score 75% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected]. 

Users must: 

  • Read the learning objectives and faculty disclosures 
  • Participate in the activity 
  • Complete the activity evaluation and attest to credit

There is no fee to participate. 

In order to claim MOC points, users must:

  • Review and successfully complete the activity
  • Proceed to the evaluation and provide your ABIM ID and date of birth

MOC points will be submitted to ABIM profiles within 6 to 8 weeks of completion. 

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources